EBRC Consulting GmbH
- Home
- Companies
- EBRC Consulting GmbH
- Services
- Active Substances Services
Active Substances Services
Dossiers in support of inclusion in Annex I of Directive 98/8/EC:For inclusion into Annex I of Directive 98/8/EC of both new and existing active substances, a comprehensive dossier has to be submitted to EU competent authorities. EBRC’s services comprise all activities necessary for a successful application:
Most popular related searches
risk assessment
environmental fate
toxicology profiling
exposure level
toxicology
hazardous substances
IUCLID
biocide
ecotoxicology
hazard assessment
- Product-type specific initial completeness check of data sets
- Identification of data gaps
- Evaluation of the validity of existing studies
- Strategy for closing data gaps, e.g. through comprehensive literature searches or conduct of new experimental studies
- Planning, coordination and monitoring of experimental studies
- Development of concepts for data waiving
- Modelling of physicochemical, toxicological and environmental substance properties [(Q)SAR]
- Evaluation of physicochemical hazards of active substances
- Assessment of the basic effectiveness of active substances
- Evaluation of the toxicological profile of active substances
- Derivation of safe exposure levels for humans: e.g. A(O)EL, ADI, …
- Evaluation of the environmental fate of active substances
- Evaluation of the ecotoxicological profile of active substances
- Derivation of PNECs (predicted no-effect concentrations of active substances
- Proposals for classification & labelling
- Preparation of complete dossiers in support of Annex I inclusion of both new and existing active substances, according to product-type specific data requirements, including all relevant risk assessments, and preparation of a comprehensive IUCLID 5 file
- Submission of dossiers and defence in the review process
- Performance of non-standard risk assessments (biostatistics, data management, etc.)
Dossiers for existing active substances had to be submitted until October 2008. If you need assistance in developing a dossier for a new active substance, please contact us.
